EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
14.09.23
/
50%
€10.20
Target price
14.09.24
€29.02
Performance (%)
-18.55%
End price
15.09.24
€8.31
Summary
This prediction ended on 15.09.24 with a price of €8.31. The price of EyePoint Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.55%. Cantor_Fitzgerald has a follow-up prediction for EyePoint Pharmaceuticals Inc. where he still thinks EyePoint Pharmaceuticals Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| EyePoint Pharmaceuticals Inc. | -4.688% | -4.688% | 31.693% |
| iShares Core DAX® | -2.680% | 2.021% | 3.062% |
| iShares Nasdaq 100 | 0.725% | 2.753% | 34.396% |
| iShares Nikkei 225® | -0.725% | 5.698% | 63.753% |
| iShares S&P 500 | 1.166% | 4.063% | 25.141% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $31.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
In the thread Trading EyePoint Pharmaceuticals Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€12.20
08.07.26
08.07.26
€41.17
08.07.27
08.07.27
6.56%
13.07.26
13.07.26
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
-6.79%
21.06.25
21.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24